ERBB2 and osteosarcoma: Proteins that are overexpressed on osteosarcoma cells, such as the glycoprotein non-metastatic B (GPNMB), the leucine-rich repeat-containing 15 (LRRC15), B7-H3, GD2, and HER2, could represent potential targets for ADCs [6].